Abstract
Chronic non-communicable diseases (NCDs) are the major causes of premature death and disability in both high-income and low- and middle-income countries (LMICs). However, there is substantial variation in the age and sex-specific rates of major NCDs that are not fully explained by differences in the distributions of established risk factors, suggesting that other important causes remain to be discovered. Population-based epidemiological studies are needed for reliable assessment of lifestyle, biochemical and genetic determinants for NCDs, and for assessing prognosis and clustering of NCDs. Moreover, analysis of genetic variants for particular traits can be used to elucidate the causal relevance of particular exposures with disease and to anticipate the likely effects of treatments. Epidemiological studies conducted in diverse populations with prolonged follow-up for both fatal and non-fatal disease outcomes can provide important evidence about the causes of NCDs that may inform disease prevention strategies globally. The aim of this chapter is to provide readers with an overview of basic concepts and the epidemiological principles that underlie the design and conduct of epidemiological studies, including the chief strengths and limitations of different study designs. Moreover, it will highlight the importance of large prospective biobank studies, which involve assessment of a sufficiently large number of participants, together with strict control of bias and confounding to be able to detect moderate relative risks of major disease outcomes reliably.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CHD:
-
Coronary heart disease
- CKB:
-
China Kadoorie Biobank
- DAG:
-
Directed acyclic graphs
- DNA:
-
Deoxyribonucleic acid
- GWAS:
-
Genome-wide association studies
- IHD:
-
Ischaemic heart disease
- IV:
-
Instrumental variable
- K:
-
1000
- MR:
-
Mendelian randomization
- MVP:
-
Million Veterans Project
- NCD:
-
Non-communicable disease
- RCT:
-
Randomized controlled trials
- STROBE:
-
Strengthening the Reporting of Observational studies in Epidemiology
- UK:
-
United Kingdom
- UKB:
-
UK Biobank
- USA:
-
United States of America
References
Baigent C, Peto R, Gray R, Staplin N, Parish S, Collins R. Large-scale randomized evidence: trials and meta-analyses of trials. Oxford: Oxford University Press; 2020.
Batty GD, Gale CR, Kivimiki M, Deary IJ, Bell S. Comparison of associations in UK Biobank against prospective general population-based studies with conventional response rates; prospective cohort studies and individual-level meta-anlyses. BMJ. 2020;12(368):M131.
Chen Z, Keech A, Collins R, Slavin B, Chen J, Campbell TC, Peto R. Prolonged hepatitis B virus and association between low blood cholesterol concentration and liver cancer. BMJ. 1993;306:890–4. https://doi.org/10.1136/bmj.306.6882.890.
Chen Z, Emberson J, Collins R. Strategic need for large prospective studies in different populations. JAMA. 2020;323:309–10. https://doi.org/10.1001/jama.2019.19736.
Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of perspective studies. Am J Epidemiol. 1999;150:341–53.
Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet. 2001;357:373–80.
Floud S, Simpson RF, Balkwill A, Brown A, Goodill A, Gallacher J, Sudlow C, Harris P, Hofman A, Parish S, Reeves GK, Green J, Peto R, Beral V. Body mass index, diet, physical activity and the incidence of dementia in 1 million UK women. Neurology. 2020;94(2):e123–32.
Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown and Co; 1987.
Keys A. Seven countries; a multivariate analysis of death and coronary heart disease. Cambridge: Harvard University Press; 1980.
Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–922.
Kirkwood BR, Sterne JAC. Essential medical statistics: Wiley-Blackwell; 2003.
Lawlor DA, Smith GD, Bruckdorfer KR, Kundu D, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet. 2004;363:1724–7.
Liu B, Floud S, Pirre K, Green J, Peto R. Beral V for the Million Women Study collaborators. Does happiness itself directly affect mortality? The prospective UK Million Women study. Lancet. 2016;387:874–81.
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease. Part I, prolonged differences in blood pressure: prospective observation studies corrected for regression dilution bias. Lancet. 1990;335:765–74.
Millwood IY, Walters RG, Mei XW, et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019;393:1831–42.
Ouellette S, Tassé AM. P(3)G - 10 years of toolbuilding: from the population biobank to the clinic. Appl Transl Genom. 2014;3:36–40.
Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22.
Sun L, Clarke R, Bennett D, et al. Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults. Nat Med. 2019;25:569–74.
Vandenbroucke JP, Broadbent A, Pearce N. Causality and causal inference in epidemiology: the need for a pluralistic approach. Int J Epidemiol. 2016;45:1776–86.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bennett, D., Clarke, R. (2020). Population-Based Health Studies: An Overview of Principles and Methods. In: Chen, Z. (eds) Population Biobank Studies: A Practical Guide. Springer, Singapore. https://doi.org/10.1007/978-981-15-7666-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-15-7666-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7665-2
Online ISBN: 978-981-15-7666-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)